COSCIENS Biopharma

COSCIENS Biopharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of COSCIENS Biopharma (CSCI.TO) as of Oct 23, 2026 is -10.37 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -14.02 M USD — a change of -26.09% (higher).

EBITDA

-10.37 MUSD

YoY

-26.09%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of COSCIENS Biopharma is 2025 -10.37 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of COSCIENS Biopharma was 2024 -14.02 M USD. It decreases by -26.09% higher compared to the previous year.

The COSCIENS Biopharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
9.90 M USD
Jan 1, 2019
-9.50 M USD
Jan 1, 2020
-6.10 M USD
Jan 1, 2021
-8.70 M USD
Jan 1, 2022
-15.20 M USD
Jan 1, 2023
-4.63 M USD
Jan 1, 2024
-14.02 M USD
Jan 1, 2025
-10.37 M USD
The COSCIENS Biopharma EBITDA history
YEAREBITDAYoY
-10.37 MUSD-26.09%
-14.02 MUSD+202.94%
-4.63 MUSD-69.55%
-15.20 MUSD+74.71%
-8.70 MUSD+42.62%
-6.10 MUSD-35.79%
-9.50 MUSD-195.96%
9.90 MUSD-143.04%
-23.00 MUSD-21.77%
-29.40 MUSD-15.76%
-34.90 MUSD0.00%
-34.90 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

COSCIENS Biopharma Stock analysis

What does COSCIENS Biopharma do? COSCIENS Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about COSCIENS Biopharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of COSCIENS Biopharma is -10.37 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of COSCIENS Biopharma changed from -14.02 M USD to -10.37 M USD, representing a -26.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) COSCIENS Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s COSCIENS Biopharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — COSCIENS Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — COSCIENS Biopharma